302 related articles for article (PubMed ID: 20236074)
1. NO to breast: when, why and why not?
Pervin S; Chaudhuri G; Singh R
Curr Pharm Des; 2010; 16(4):451-62. PubMed ID: 20236074
[TBL] [Abstract][Full Text] [Related]
2. [To stimulate or to inhibit nitric oxide production in mammary tumors?].
Gauthier N; Arnould L; Chantôme A; Reisser D; Bettaieb A; Reveneau S; Jeannin JF
Bull Cancer; 2004 Sep; 91(9):705-12. PubMed ID: 15544996
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line.
Lahiri M; Martin JH
Oncol Rep; 2004 Nov; 12(5):1007-11. PubMed ID: 15492785
[TBL] [Abstract][Full Text] [Related]
4. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
[TBL] [Abstract][Full Text] [Related]
5. Targeting nitric oxide for tumor therapy.
Contestabile A
Curr Pharm Des; 2010; 16(4):378-80. PubMed ID: 20236066
[No Abstract] [Full Text] [Related]
6. Flavone inhibits nitric oxide synthase (NOS) activity, nitric oxide production and protein S-nitrosylation in breast cancer cells.
Zhu W; Yang B; Fu H; Ma L; Liu T; Chai R; Zheng Z; Zhang Q; Li G
Biochem Biophys Res Commun; 2015 Mar; 458(3):590-595. PubMed ID: 25680459
[TBL] [Abstract][Full Text] [Related]
7. The Involvement of Arginase and Nitric Oxide Synthase in Breast Cancer Development: Arginase and NO Synthase as Therapeutic Targets in Cancer.
Avtandilyan N; Javrushyan H; Petrosyan G; Trchounian A
Biomed Res Int; 2018; 2018():8696923. PubMed ID: 29854802
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and cancer therapy: the emperor has NO clothes.
Hickok JR; Thomas DD
Curr Pharm Des; 2010; 16(4):381-91. PubMed ID: 20236067
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines.
Zeillinger R; Tantscher E; Schneeberger C; Tschugguel W; Eder S; Sliutz G; Huber JC
Breast Cancer Res Treat; 1996; 40(2):205-7. PubMed ID: 8879687
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence.
Martin JH; Alalami O; van den Berg HW
Cancer Lett; 1999 Sep; 144(1):65-74. PubMed ID: 10503879
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes.
Jaiswal M; LaRusso NF; Shapiro RA; Billiar TR; Gores GJ
Gastroenterology; 2001 Jan; 120(1):190-9. PubMed ID: 11208728
[TBL] [Abstract][Full Text] [Related]
12. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.
Loibl S; von Minckwitz G; Weber S; Sinn HP; Schini-Kerth VB; Lobysheva I; Nepveu F; Wolf G; Strebhardt K; Kaufmann M
Cancer; 2002 Sep; 95(6):1191-8. PubMed ID: 12216084
[TBL] [Abstract][Full Text] [Related]
13. Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts.
Harris SR; Schoeffner DJ; Yoshiji H; Thorgeirsson UP
Cancer Lett; 2002 May; 179(1):95-101. PubMed ID: 11880187
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase: Good or bad?
Lind M; Hayes A; Caprnda M; Petrovic D; Rodrigo L; Kruzliak P; Zulli A
Biomed Pharmacother; 2017 Sep; 93():370-375. PubMed ID: 28651238
[TBL] [Abstract][Full Text] [Related]
15. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
Grumbach IM; Chen W; Mertens SA; Harrison DG
J Mol Cell Cardiol; 2005 Oct; 39(4):595-603. PubMed ID: 16099468
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
[TBL] [Abstract][Full Text] [Related]
17. Antioxidative response for nitric oxide production in breast carcinoma.
Karihtala P; Kinnula VL; Soini Y
Oncol Rep; 2004 Oct; 12(4):755-9. PubMed ID: 15375496
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide produced by inducible nitric oxide synthase is associated with mammary tumorigenesis in irradiated rats.
Inano H; Onoda M
Nitric Oxide; 2005 Feb; 12(1):15-20. PubMed ID: 15631943
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells.
Martin JH; Alalami O; Yaqoob F
Oncol Rep; 2000; 7(2):219-23. PubMed ID: 10671661
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the nitric oxide synthase-nitric oxide-cGMP pathway in rat mesenteric endothelial cells.
Papapetropoulos A; Andreopoulos S; Go CY; Hoque A; Fuchs LC; Catravas JD
J Appl Physiol (1985); 2001 Dec; 91(6):2553-60. PubMed ID: 11717218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
